Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q4 EPS by 11c; Guides FY13

February 26, 2013 7:05 AM EST Send to a Friend
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q4 EPS of $1.83, $0.11 better than the analyst estimate of $1.72. Revenue for the quarter came in at $172.5 million versus the consensus estimate of $171.2 million.

Sees FY2013 revenue of $325-355 million, versus the consensus of $342.30 million. Net income on a non-GAAP basis will be in the range of $18 to $23 million.

For earnings history and earnings-related data on Auxilium Pharmaceuticals, Inc. (AUXL) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment